NCT04801615

Brief Summary

To study the demographic characteristic of patients with necrotizing soft tissue infections.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 23, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 7, 2023

Status Verified

August 1, 2023

Enrollment Period

4.3 years

First QC Date

December 23, 2020

Last Update Submit

August 3, 2023

Conditions

Necrotizing Soft Tissue Infection

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients that dies within 1 year following admission date

    The risk of death within 1 year

    12 months following admission date

Interventions

SurgeryOTHER

All patients in the database undergo surgery due to a suspicion of necrotizing soft tissue infections

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients admitted to Aarhus University Hospital with necrotizing soft tissue infections, either diagnosed prior to arriving to the hospital or diagnosed in the hospital.

You may qualify if:

  • Patients diagnosed with necrotizing soft tissue infections and treated at Aarhus Universital Hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus N, 8200, Denmark

RECRUITING

MeSH Terms

Interventions

Surgical Procedures, Operative

Study Officials

  • per gundtoft

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

per gundtoft

CONTACT

26195112pergun@rm.dk

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Consultant, PhD

Study Record Dates

First Submitted

December 23, 2020

First Posted

March 17, 2021

Study Start

September 1, 2020

Primary Completion

January 1, 2025

Study Completion

June 1, 2025

Last Updated

August 7, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

We do not plan to share this with other researchers.

Locations

DK(1)